AstraZeneca COVID vaccine sales jump to $894 mln, updates forecasts


Reuters | Updated: 29-07-2021 11:58 IST | Created: 29-07-2021 11:47 IST
AstraZeneca COVID vaccine sales jump to $894 mln, updates forecasts
Representative Image
  • Country:
  • United States

AstraZeneca's COVID-19 vaccine sales more than tripled to $894 million in the second quarter from the previous three months but shaved off 1 U.S. cent from earnings, and the drugmaker updated its 2021 forecasts on Thursday to include sales from its Alexion unit.

Also Read: Thailand says AstraZeneca seeks to delay delivery of 61 mln vaccine doses

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback